BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18230572)

  • 1. [Methionine dependency of cancer cells: a new therapeutic approach?].
    Durando X; Thivat E; Gimbergues P; Cellarier E; Abrial C; Dib M; Tacca O; Chollet P
    Bull Cancer; 2008 Jan; 95(1):69-76. PubMed ID: 18230572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine dependency and cancer treatment.
    Cellarier E; Durando X; Vasson MP; Farges MC; Demiden A; Maurizis JC; Madelmont JC; Chollet P
    Cancer Treat Rev; 2003 Dec; 29(6):489-99. PubMed ID: 14585259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methionine-stress: a pleiotropic approach in enhancing the efficacy of chemotherapy.
    Kokkinakis DM
    Cancer Lett; 2006 Feb; 233(2):195-207. PubMed ID: 16520149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment.
    Miki K; Al-Refaie W; Xu M; Jiang P; Tan Y; Bouvet M; Zhao M; Gupta A; Chishima T; Shimada H; Makuuchi M; Moossa AR; Hoffman RM
    Cancer Res; 2000 May; 60(10):2696-702. PubMed ID: 10825143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial L-methioninase: production, molecular characterization, and therapeutic applications.
    El-Sayed AS
    Appl Microbiol Biotechnol; 2010 Mar; 86(2):445-67. PubMed ID: 20146062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer.
    Thivat E; Durando X; Demidem A; Farges MC; Rapp M; Cellarier E; Guenin S; D'Incan M; Vasson MP; Chollet P
    Anticancer Res; 2007; 27(4C):2779-83. PubMed ID: 17695447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial.
    Durando X; Thivat E; Farges MC; Cellarier E; D'Incan M; Demidem A; Vasson MP; Barthomeuf C; Chollet P
    Nutr Cancer; 2008; 60(1):23-30. PubMed ID: 18444132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension.
    Cavuoto P; Fenech MF
    Cancer Treat Rev; 2012 Oct; 38(6):726-36. PubMed ID: 22342103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of serum methionine by methioninase in mice.
    Lishko VK; Lishko OV; Hoffman RM
    Anticancer Res; 1993; 13(5A):1465-8. PubMed ID: 8239522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine depletion modulates the antitumor and antimetastatic efficacy of ethionine.
    Guo H; Tan Y; Kubota T; Moossa AR; Hoffman RM
    Anticancer Res; 1996; 16(5A):2719-23. PubMed ID: 8917377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined methionine deprivation and chloroethylnitrosourea have time-dependent therapeutic synergy on melanoma tumors that NMR spectroscopy-based metabolomics explains by methionine and phospholipid metabolism reprogramming.
    Guénin S; Morvan D; Thivat E; Stepien G; Demidem A
    Nutr Cancer; 2009; 61(4):518-29. PubMed ID: 19838924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research development of tumor treatment with methionine gamma-lyase].
    Fu W; Tian C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Aug; 28(4):839-42. PubMed ID: 21936392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine Restriction: Ready for Prime Time in the Cancer Clinic?
    Yamamoto J; Han Q; Simon M; Thomas D; Hoffman RM
    Anticancer Res; 2022 Feb; 42(2):641-644. PubMed ID: 35093861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositis.
    Vuyyuri SB; Hamstra DA; Khanna D; Hamilton CA; Markwart SM; Campbell KC; Sunkara P; Ross BD; Rehemtulla A
    Clin Cancer Res; 2008 Apr; 14(7):2161-70. PubMed ID: 18381958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methioninase: a therapeutic for diseases related to altered methionine metabolism and transmethylation: cancer, heart disease, obesity, aging, and Parkinson's disease.
    Hoffman RM
    Hum Cell; 1997 Mar; 10(1):69-80. PubMed ID: 9234067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients.
    Tan Y; Zavala J; Han Q; Xu M; Sun X; Tan X; Tan X; Magana R; Geller J; Hoffman RM
    Anticancer Res; 1997; 17(5B):3857-60. PubMed ID: 9427792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review.
    Kawaguchi K; Han Q; Li S; Tan Y; Igarashi K; Murakami T; Unno M; Hoffman RM
    Cells; 2019 May; 8(5):. PubMed ID: 31052611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary Methionine Restriction-Based Cancer Chemotherapy in Rodents.
    Hoffman RM; Stern PH
    Methods Mol Biol; 2019; 1866():83-94. PubMed ID: 30725410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nutritional and enzymatic methionine deprivation upon human normal and malignant cells in tissue culture.
    Kreis W; Baker A; Ryan V; Bertasso A
    Cancer Res; 1980 Mar; 40(3):634-41. PubMed ID: 6937240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methionine gamma-lyase: the unique reaction mechanism, physiological roles, and therapeutic applications against infectious diseases and cancers.
    Sato D; Nozaki T
    IUBMB Life; 2009 Nov; 61(11):1019-28. PubMed ID: 19859976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.